U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938918) titled 'Non-Invasive Screening for Embryo Chromosome Abnormalities Using Growth Patterns and Culture Fluid Analysis' on Nov. 10.

Brief Summary: For Couples undergoing in vitro fertilization (IVF), one of the most important decisions is choosing which embryo has the best chance of leading to a healthy pregnancy. Today, this often relies on a biopsy, where a few cells are removed from the embryo for genetic testing (PGT-A). This technique has shown high accuracy; however, this test is invasive, adds cost, and involves handling the embryo directly.

The Prediction of Embryo Aneuploidy using Non-invasive Morphokinetics and Culture Media Readout...